innovation in heart and vascular science
From EMPA-REG to Clinical Practice: Mastering SGLT2 Inhibitors in Modern Cardiology
Dr Zieroth provides a comprehensive update on how SGLT2 inhibitors transformed from anti-diabetic agents into cardiovascular powerhouses, delivering highly significant reductions in cardiovascular death and heart failure hospitalization. She explores how these medications have become fundamental pillars of cardio-kidney-metabolic medicine, with evidence spanning the entire ejection fraction spectrum.
Listen →